INCORPORATION OF INVITRO ENZYME DATA INTO THE PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR METHYLENE-CHLORIDE - IMPLICATIONS FOR RISK ASSESSMENT

被引：73
|
作者：
REITZ, RH
MENDRALA, AL
PARK, CN
ANDERSEN, ME
GUENGERICH, FP
机构：
[1] USAF,ARMSTRONG AEROSP MED RES LAB,WRIGHT PATTERSON AFB,OH 45433
[2] VANDERBILT UNIV,DEPT BIOCHEM,NASHVILLE,TN 37240
来源：
TOXICOLOGY LETTERS | 1988年 / 43卷 / 1-3期
关键词：
D O I：
10.1016/0378-4274(88)90023-9
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：97 / 116
页数：20
相关论文
共 26 条
  • [1] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [2] MICROCOMPUTER PROGRAMS FOR PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODELING
    DONG, MH
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 1994, 45 (03) : 213 - 221
  • [3] A physiologically-based pharmacokinetic (PB-PK) model for ethylene dibromide: relevance of extrahepatic metabolism
    Hissink, AM
    Wormhoudt, LW
    Sherratt, PJ
    Hayes, JD
    Commandeur, JNM
    Vermeulen, NPE
    van Bladeren, PJ
    FOOD AND CHEMICAL TOXICOLOGY, 2000, 38 (08) : 707 - 716
  • [4] SENSITIVITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS TO VARIATION IN MODEL PARAMETERS - METHYLENE-CHLORIDE
    CLEWELL, HJ
    LEE, TS
    CARPENTER, RL
    RISK ANALYSIS, 1994, 14 (04) : 521 - 531
  • [5] VALIDATION OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL USED TO SIMULATE ABSORBED MALATHION DOSES IN HUMANS
    DONG, MH
    THONGSINTHUSAK, T
    ROSS, JH
    KRIEGER, RI
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 65 - AGRO
  • [6] SIMULATIONS OF SHORT-TERM-IV AMIODARONE DOSING WITH A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL
    HOU, ZY
    BALTER, NJ
    CHEN, CY
    WOOSLEY, RL
    SCHWARTZ, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 174 - 174
  • [7] PHYSIOLOGICALLY BASED PHARMACOKINETICS AND THE RISK ASSESSMENT PROCESS FOR METHYLENE-CHLORIDE
    ANDERSEN, ME
    CLEWELL, HJ
    GARGAS, ML
    SMITH, FA
    REITZ, RH
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1987, 87 (02) : 185 - 205
  • [8] USE OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) NICOTINE-COTININE MODEL TO ASSESS THE INFLUENCE OF NICOTINE ON THE DISTRIBUTION OF COTININE IN MAN
    ROBINSON, DE
    BALTER, NJ
    SCHWARTZ, SL
    FASEB JOURNAL, 1991, 5 (06): : A1568 - A1568
  • [9] INVITRO METABOLISM OF METHYLENE-CHLORIDE IN HUMAN AND ANIMAL-TISSUES - USE IN PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    REITZ, RH
    MENDRALA, AL
    GUENGERICH, FP
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 97 (02) : 230 - 246
  • [10] Evaluating a physiologically-based pharmacokinetic model for use in risk assessment.
    Clark, LH
    Barton, HA
    Setzer, RW
    TOXICOLOGICAL SCIENCES, 2003, 72 : 182 - 182
123